These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17390091)

  • 1. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein.
    Beerens AM; Rots MG; de Vries EF; Haisma HJ
    Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
    Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
    J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
    Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
    J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
    J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.
    Luo C; Nawa A; Yamauchi Y; Kohno S; Ushijima Y; Goshima F; Kikkawa F; Nishiyama Y
    Virus Genes; 2007 Jun; 34(3):263-72. PubMed ID: 16927131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.
    Dilber MS; Phelan A; Aints A; Mohamed AJ; Elliott G; Smith CI; O'Hare P
    Gene Ther; 1999 Jan; 6(1):12-21. PubMed ID: 10341871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
    Kong BH; Wang WX; Liu CS; Ma DX; Qu X
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of thymidine kinase to increase the effectivity of suicide gene therapy results in the loss of enzymatic activity.
    Beerens AM; Rots MG; Bermúdez B; de Vries EF; Haisma HJ
    J Drug Target; 2008 Jan; 16(1):26-35. PubMed ID: 18172817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument protein.
    Bamdad T; Bell JC
    Iran Biomed J; 2007 Jan; 11(1):53-7. PubMed ID: 18051705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
    Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
    In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
    Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG
    Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.
    Roy V; Qiao J; de Campos-Lima P; Caruso M
    Gene Ther; 2005 Jan; 12(2):169-76. PubMed ID: 15483667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22.
    Xue X; Huang J; Wang H
    PLoS One; 2014; 9(6):e100840. PubMed ID: 24955582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22.
    Qiu Z; Harms JS; Zhu J; Splitter GA
    J Virol; 2004 Apr; 78(8):4224-33. PubMed ID: 15047837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
    Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
    J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
    Bennour E; Ferrand C; Rémy-Martin JP; Certoux JM; Gorke S; Qasim W; Gaspar HB; Baumert T; Duperrier A; Deschamps M; Fehse B; Tiberghien P; Robinet E
    Hum Gene Ther; 2008 Jul; 19(7):699-709. PubMed ID: 18557699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for intercellular trafficking of VP22 in living cells.
    Lemken ML; Wolf C; Wybranietz WA; Schmidt U; Smirnow I; Bühring HJ; Mack AF; Lauer UM; Bitzer M
    Mol Ther; 2007 Feb; 15(2):310-9. PubMed ID: 17235309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
    Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
    Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.